Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
March 13, 2024
Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs
Rishi R Shah, Elena De Vita, Preethi S Sathyamurthi, et al.
Bioorganic & Medicinal Chemistry
|
February 23, 2019
Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline
Adrian Blaser, Hamish S Sutherland, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry
|
February 28, 2018
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles
Hamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
European Journal of Medicinal Chemistry
|
December 28, 2021
Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
Hamish S Sutherland, Guo-Liang Lu, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry
|
February 27, 2019
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
Hamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Bioorganic & Medicinal Chemistry
|
June 30, 2022
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy
Maria Chatzopoulou, Daniel Conole, Enrico Emer, et al.
Bioorganic & Medicinal Chemistry
|
October 2, 2020
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
Guo-Liang Lu, Amy S T Tong, Daniel Conole, et al.
ACS Medicinal Chemistry Letters
|
October 24, 2017
6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
Amy S T Tong, Peter J Choi, Adrian Blaser, et al.
Chemical Communications (Cambridge, England)
|
September 6, 2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, et al.
Oncogene
|
May 31, 2020
Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer
Bruno M Simões, Angélica Santiago-Gómez, Chiara Chiodo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
March 13, 2024
Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs
Rishi R Shah, Elena De Vita, Preethi S Sathyamurthi, et al.
Bioorganic & Medicinal Chemistry
|
February 23, 2019
Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline
Adrian Blaser, Hamish S Sutherland, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry
|
February 28, 2018
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles
Hamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
European Journal of Medicinal Chemistry
|
December 28, 2021
Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
Hamish S Sutherland, Guo-Liang Lu, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry
|
February 27, 2019
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
Hamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Bioorganic & Medicinal Chemistry
|
June 30, 2022
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy
Maria Chatzopoulou, Daniel Conole, Enrico Emer, et al.
Bioorganic & Medicinal Chemistry
|
October 2, 2020
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
Guo-Liang Lu, Amy S T Tong, Daniel Conole, et al.
ACS Medicinal Chemistry Letters
|
October 24, 2017
6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
Amy S T Tong, Peter J Choi, Adrian Blaser, et al.
Chemical Communications (Cambridge, England)
|
September 6, 2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, et al.
Oncogene
|
May 31, 2020
Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer
Bruno M Simões, Angélica Santiago-Gómez, Chiara Chiodo, et al.
Page
of 4